Abstract
Withania somnifera is wonder shrub used traditionally as a folk medicine for several remedies in the Indian subcontinent. During last few decades numerous scientific studies have shown the potential therapeutic prospects of this herb and of its various constituents in different disease models. Several classes of compounds including withanolides, sitoindosides and other useful alkaloids have been isolated from this plant with promising medicinal value. It has been demonstrated that different parts of plant including roots, leaves and fruits exhibit unique biological activities that actually are manifested to the presence and the abundance of specific constituent/s in the respective parts of the plant. It was also established that same plant grown at different locations under varied environmental conditions influences the synthesis of the individual constituents in different parts of the plant, hence their biological activities. Studies conducted in cellular and murine models have shown that extracts made of roots bear immune activating properties, whereas leaf extracts showed anticancer activities. It has been observed that root and leaf extracts of plant characterised with about a dozen markers displayed that root extracts demonstrated Th1 specific immunomodulatory and anti-inflamatory activities, whereas leaf extracts showed anticancer properties, respectively. It was further explored that anti-cancer potential of leaf extracts was mainly due to Withaferin A, a potent cytotoxic withanoloid, existing in abundance and a major constituent in the leaves of the plant. Similarly, anti-inflammatory and Th1 immune skewing properties of the root extract was conferred to the higher amount of Withanolide A, present in the roots of the plant along with other constituents. Meanwhile several studies have deciphered the role of individual constituents in various biological activities with extensive mechanism of action discussed in this review. This review while summarises the potential medicinal benefits of the W.somnifera, it also emphasizes that marketed product of the plant extracts for human consumption should scientifically validated for bioactive constitutents.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ahmad MK, Mahdi AA, Shukla KK, Islam N, Rajender S, Madhukar D, Shankhwar SN, Ahmad S (2010) Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril 94(3):989–996
Ali NA, Julich WD, Kusnick C, Lindequist U (2001) Screening of Yemeni medicinal plants for antibacterial and cytotoxic activities. J Ethnopharmacol 74:173–179
Anbalagan K, Sadique J (1981) Influence of an Indian medicine (Ashwagandha) on acute-phase reactants in inflammation. Indian J Exp Biol 19:245–249
Andrade C, Aswath A, Chaturvedi SK, Srinivasa M, Raguram R (2000) A double-blind, placebo-controlled evaluation of the anxiolytic efficacy of an ethanolic extract of Withania Somnifera. Ind J Psychaitry 42:295–301
Archana R, Namasivayam A (1999) Antistressor effect of Withania somnifera. J Ethnopharmacol 64:91–39
Bahr V, Hansel R (1970) Immunomodulating properties of 5,20 alpha (R)-dihydroxy-6 alpha,7 alpha-epoxy-1-oxo-(5 alpha)-whitha-2,24-dienolide and solasodine. Planta Med 44:32–33
Bhandari C (1970) Ashwagandha (Withania somnifera)“Vanaushadhi Chandroday”(An Encyclopedia of Indian Herbs), vol 1. CS Series of Varanasi Vidyavilas Press, Varanasi, pp 96–97
Bhattacharya SK, Muruganandam AV (2003) Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav 75:547–555
Bhattacharya A, Ghosal S, Bhattacharya SK (2001) Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 74:1–6
Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI (2013) Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther 12:312–322
Budhiraja RD, Sudhir S, Garg KN (1984) Anti-inflammatory activity of 3 beta-hydroxy-2,3-dihydro-withanolide F. Planta Med 50:134–136
Budhiraja R, Krishan P, Sudhir S (2000) Biological activity of withanolides. J Sci Ind Res 59:904–911
Chandra S, Chatterjee P, Dey P, Bhattacharya S (2012) Evaluation of anti-inflammatory effect of Ashwagandha: a preliminary study in vitro. Phcog J 4:47–49
Chandrasekhar K, Kapoor J, Anishetty S (2012) A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of Ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med 34:255–262
Chaudhary G, Sharma U, Jagannathan NR, Gupta YK (2003) Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats. Clin Exp Pharmacol Physiol 30:399–404
Choudhary MI, Dur ES, Parveen Z, Jabbar A, Ali I, Atta-ur R (1995) Antifungal steroidal lactones from Withania coagulance. Phytochemistry 40:1243–1246
Cohen SM, Mukerji R, Timmermann BN, Samadi AK, Cohen MS (2012) A novel combination of withaferin A and sorafenib shows synergistic efficacy against both papillary and anaplastic thyroid cancers. Am J Surg 204: 895–900; discussion -1
Cooley K, Szczurko O, Perri D, Mills EJ, Bernhardt B, Zhou Q, Seely D (2009) Naturopathic care for anxiety: a randomized controlled trial ISRCTN78958974. PLoS One 4:e6628
Davis L, Kuttan G (2000) Immunomodulatory activity of Withania somnifera. J Ethnopharmacol 71:193–200
Davis L, Kuttan G (2002) Effect of Withania somnifera on CTL activity. J Exp Clin Cancer Res 21:115–118
Devi PU, Sharada AC, Solomon FE, Kamath MS (1992) In vivo growth inhibitory effect of Withania somnifera (Ashwagandha) on a transplantable mouse tumor, sarcoma 180. Indian J Exp Biol 30:169–172
Dhar RS, Gupta SB, Singh PP, Razdan S, Bhat WW, Rana S, Lattoo SK, Khan S (2012) Identification and characterization of protein composition in Withania somnifera-an Indian ginseng. J Plant Biochem Biotechnol 21:77–87
Dhuley JN (1998a) Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol 70:57–63
Dhuley JN (1998b) Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol 60:173–178
Dickson TC, Vickers JC (2001) The morphological phenotype of beta-amyloid plaques and associated neuritic changes in Alzheimer’s disease. Neuroscience 105:99–107
Dwivedi S, Gupta D, Sharma K, Kumar S, Kukreja A, Dwivedi S, Singh AK (2000) Modification of coronary risk factors by medicinal plants. J Med Aroma Plant Sci 22:616–620
Eastwood FW, Kirson I, Lavie D, Abraham A (1980) New withanolides from a cross of a South African chemotype by chemotype II (Israel) in Withania somnifera. Phytochemistry 19:1503–1507
Gauttam VK, Kalia AN (2013) Development of polyherbal antidiabetic formulation encapsulated in the phospholipids vesicle system. J Adv Pharm Technol Res 4:108–117
Gorain M, Ahmed S, Bhandari R, Sharma N (2012) Biology of Phalantha Phalantha Drary (Nymphalidae: Lepidoptera)-an injurious pest of well-known medicinal plant Withania Somnifera Dunal. Biotech Res 2:4–6
Govardhan S (1938) Ashwagandharishta – Rastantra Sar Evam Sidhyaprayog Sangrah. Krishna–Gopal Ayurveda Bhawan (Dharmarth Trust), Nagpur, pp 743–744
Grover A, Shandilya A, Agrawal V, Bisaria VS, Sundar D (2012) Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn 29:651–662
Gu M, Yu Y, Gunaherath GM, Gunatilaka AA, Li D, Sun D (2014) Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. Investig New Drugs 32:68–74
Gupta A, Mahdi AA, Shukla KK, Ahmad MK, Bansal N, Sankhwar P, Sankhwar SN (2013) Efficacy of Withania somnifera on seminal plasma metabolites of infertile males: a proton NMR study at 800 MHz. J Ethnopharmacol 149:208–214
Iqbal CM, Abbas S, Arshad JS (1996) Withania somnifera: a source of exotic withanolides. Heterocycles 42:555–563
Jain S, Shukla SD, Sharma K, Bhatnagar M (2001) Neuroprotective effects of Withania somnifera Dunn. in hippocampal sub-regions of female albino rat. Phytother Res 15:544–548
Kakar SS, Ratajczak MZ, Powell KS, Moghadamfalahi M, Miller DM, Batra SK, Singh SK (2014) Withaferin a alone and in combination with Cisplatin suppresses growth and metastasis of ovarian cancer by targeting putative cancer stem cells. PLoS One 9:e107596
Kapur LD (2001) Handbook of ayurvedic medicinal plants. CRC Press, London
Kaur K, Widodo N, Nagpal A, Kaul SC, Wadhwa R (2007) Sensitization of human cancer cells to anti-cancer drugs by leaf extract of Ashwagandha (LASH). Tiss Cult Res Commun 26:193–199
Khan PM, Ahmad S, Rubnawaz H, Malik A (1999) The first report of a withanolide from the family Labiatae. Phytochemistry 51:669–671
Kour K, Pandey A, Suri KA, Satti NK, Gupta KK, Bani S (2009) Restoration of stress-induced altered T cell function and corresponding cytokines patterns by Withanolide A. Int Immunopharmacol 9:1137–1144
Kritikar KR, Basu BD (1935) Withania somnifera. In: Lalit Mohan Basu A (ed) Indian medicinal plants, pp 1774–1776
Kuboyama T, Tohda C, Zhao J, Nakamura N, Hattori M, Komatsu K (2002) Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuro Report 13:1715–1720
Kuboyama T, Tohda C, Komatsu K (2005) Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 144:961–971
Kulkarni SK, Dhir A (2008) Withania somnifera: an Indian ginseng. Prog Neuro-Psychopharmacol Biol Psychiatry 32:1093–1105
Kulkarni RR, Patki PS, Jog VP, Gandage SG, Patwardhan B (1991) Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 33:91–95
Kumar A, Kaul M, Bhan M, Khanna PK, Suri K (2007) Morphological and chemical variation in 25 collections of the Indian medicinal plant, Withania somnifera (L.) Dunal (Solanaceae). Genet Resour Crop Evol 54:655–660
Kuttan G (1996) Use of Withania somnifera Dunal as an adjuvant during radiation therapy. Indian J Exp Biol 34:854–856
Leet J, Hussain SF, Minard R, Shamma M (1982) Sindamine, Punjabine and Gilgitine-3 New secobisbenzylisoquinoline alkaloids. Heterocycles 19:2355–2360
Linder S (1996) Withania somnifera: winter cherry, Indian ginseng, ashwagandha. Aust J Med Herb 8:78
Majumdar D (1955) Withania somnifera Dunal, part II: alkaloidal constituents and their chemical characterisation. Indian J Pharm 17:158–168
Malara N, Foca D, Casadonte F, Sesto MF, Macrina L, Santoro L, Scaramuzzino M, Terracciano R, Savino R (2008) Simultaneous inhibition of the constitutively activated nuclear factor kappaB and of the interleukin-6 pathways is necessary and sufficient to completely overcome apoptosis resistance of human U266 myeloma cells. Cell Cycle 7:3235–3245
Malik F, Singh J, Khajuria A, Suri KA, Satti NK, Singh S, Kaul MK, Kumar A, Bhatia A, Qazi GN (2007) A standardized root extract of Withania somnifera and its major constituent withanolide-A elicit humoral and cell-mediated immune responses by up regulation of Th1-dominant polarization in BALB/c mice. Life Sci 80:1525–1538
Malik F, Kumar A, Bhushan S, Mondhe DM, Pal HC, Sharma R, Khajuria A, Singh S, Singh G, Saxena AK, Suri KA, Qazi GN, Singh J (2009) Immune modulation and apoptosis induction: two sides of antitumoural activity of a standardised herbal formulation of Withania somnifera. Eur J Cancer 45:1494–1509
Mandal C, Dutta A, Mallick A, Chandra S, Misra L, Sangwan RS (2008) Withaferin A induces apoptosis by activating p38 mitogen-activated protein kinase signaling cascade in leukemic cells of lymphoid and myeloid origin through mitochondrial death cascade. Apoptosis 13:1450–1464
Mehta AK, Binkley P, Gandhi SS, Ticku MK (1991) Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. Indian J Med Res 94:312–315
Mir BA, Khazir J, Mir NA, T-u H, Koul S (2012) Botanical, chemical and pharmacological review of Withania somnifera (Indian ginseng): an ayurvedic medicinal plant. Indian J Drugs and Dis 1:147–160
Mirjalili MH, Fakhr-Tabatabaei SM, Alizadeh H, Ghassempour A, Mirzajani F (2009a) Genetic and Withaferin A analysis of Iranian natural populations of Withania somnifera and W. coagulans by RAPD and HPTLC. Nat Prod Commun 4:337–346
Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J (2009b) Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules 14:2373–2393
Mishra B (2004) Ashwagandha – Bhavprakash Nigantu (Indian Materia Medica). Chaukhambha Bharti Academy, Varanasi, pp 393–394
Mishra L-C, Singh BB, Dagenais S (2000) Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 5:334–346
Mohan R, Hammers HJ, Bargagna-Mohan P, Zhan XH, Herbstritt CJ, Ruiz A, Zhang L, Hanson AD, Conner BP, Rougas J, Pribluda VS (2004) Withaferin A is a potent inhibitor of angiogenesis. Angiogenesis 7:115–122
Mohanty I, Arya DS, Dinda A, Talwar KK, Joshi S, Gupta SK (2004) Mechanisms of cardioprotective effect of Withania somnifera in experimentally induced myocardial infarction. Basic Clin Pharmacol Toxicol 94:184–190
Mondal S, Mandal C, Sangwan R, Chandra S (2010) Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Mol Cancer 9:239
Muralikrishnan G, Dinda AK, Shakeel F (2010) Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Investig 39:688–698
Murthy HN, Dijkstra C, Anthony P, White DA, Davey MR, Power JB, Hahn EJ, Paek KY (2008) Establishment of Withania somnifera hairy root cultures for the production of withanolide A. J Integr Plant Biol 50:975–981
Oh JH, Kwon TK (2009) Withaferin A inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules by inactivation of Akt and NF-kappaB in human pulmonary epithelial cells. Int Immunopharmacol 9:614–619
Ojha SK, Arya DS (2009) Withania somnifera Dunal (Ashwagandha): a promising remedy for cardiovascular diseases. World J Med Sci 4:156–158
Palyi I (1969) Phagocytosis in HeLa cell cultures induced by anti-cancer drugs. Arch Geschwulstforsch 33:345–349
Panjamurthy K, Manoharan S, Nirmal MR, Vellaichamy L (2009) Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis. Investig New Drugs 27:447–452
Park HJ, Rayalam S, Della-Fera MA, Ambati S, Yang JY, Baile CA (2008) Withaferin A induces apoptosis and inhibits adipogenesis in 3T3-L1 adipocytes. Biofactors 33:137–148
Patil SP, Maki S, Khedkar SA, Rigby AC, Chan C (2010) Withanolide A and asiatic acid modulate multiple targets associated with amyloid-beta precursor protein processing and amyloid-beta protein clearance. J Nat Prod 73:1196–1202
Pingali U, Pilli R, Fatima N (2014) Effect of standardized aqueous extract of Withania somnifera tests of cognitive and psychomotor performance in healthy human participants. Pharm Res 6:12–18
Rahman AU, Abbas S, Shahwar DE, Jamal S, Choudhary M (1993) New withanolides from Withania spp. J Nat Prod 56:1000–1006
Rayees S, Johri RK, Singh G, Tikoo MK, Singh S, Sharma SC, Satti NK, Gupta VK, Bedi YS (2012) Sitopaladi, a poly-herbal formulation inhibits IgE mediated allergic reactions. Spatula DD 2:75–82
Rayees S, Kumar A, Rasool S, Kaiser P, Satti NK, Sangwan PL, Singh S, Johri RK, Singh G (2013) Ethanolic extract of Alternanthera sessilis (AS-1) inhibits IgE-mediated allergic response in RBL-2H3 cells. Immunol Investig 42:470–480
Rayees S, Satti NK, Mehra R, Nargotra A, Rasool S, Sharma A, Sahu PK, Rajnikant GVK, Nepali K, Singh G (2014) Anti-asthmatic activity of azepino [2, 1-b] quinazolones, synthetic analogues of vasicine, an alkaloid from Adhatoda vasica. Med Chem Res 23:1–11
Roumy V, Biabiany M, Hennebelle T, Aliouat el M, Pottier M, Joseph H, Joha S, Quesnel B, Alkhatib R, Sahpaz S, Bailleul F (2010) Antifungal and cytotoxic activity of withanolides from Acnistus arborescens. J Nat Prod 73:1313–1317
Sangwan R, Chaurasiya N, Misra L, Lal P, Uniyal G, Sharma R, Sangwan NS, Suri KA, Qazi GN (2004) Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha). Curr Sci 86:461–465
Santagata S, Xu YM, Wijeratne EM, Kontnik R, Rooney C, Perley CC, Kwon H, Clardy J, Kesari S, Whitesell L, Lindquist S, Gunatilaka AA (2012) Using the heat-shock response to discover anticancer compounds that target protein homeostasis. ACS Chem Biol 7:340–349
Sarkar S, Mandal C, Sangwan R (2014) Coupling G2/M arrest to the Wnt/beta-catenin pathway restrains pancreatic adenocarcinoma. Endocr Relat Cancer 21:113–125
Shah N, Kataria H, Kaul SC, Ishii T, Kaur G, Wadhwa R (2009) Effect of the alcoholic extract of Ashwagandha leaves and its components on proliferation, migration, and differentiation of glioblastoma cells: combinational approach for enhanced differentiation. Cancer Sci 100:1740–1747
Sharma H, Parihar L, Parihar P (2011) Review on cancer and anticancerous properties of some medicinal plants. J Med Plant Res 5:1818–1835
Shohat B, Kirson I, Lavie D (1978) Immunosuppressive activity of two plant steroidal lactones withaferin A and withanolide E. Biomedica 28:18–24
Shukla KK, Mahdi AA, Mishra V, Rajender S, Sankhwar SN, Patel D, Das M (2011) Withania somnifera Improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations. Reprod Bio Med Online 22:421–427
Singh S, Kumar S (1998) Withania somnifera: the Indian ginseng ashwagandha. Central Institute of Medicinal and Aromatic Plants, Lucknow
Singh N, Singh S, Nath C, Kohli R, Bhargava K (1984) Anti-stress plants as anti-rheumatic agents. 5th sepal congress of rheumatology, Bangkok
Singh D, Aggarwal A, Maurya R, Naik S (2007) Withania somnifera Inhibits NF-κB and AP-1 transcription factors in human peripheral blood and synovial fluid mononuclear cells. Phytother Res 21:905–913
Singh N, Bhalla M, de Jager P, Gilca M (2011) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda. Afr J Tradit Complement Altern Med 8:208–213
Soman S, Korah PK, Jayanarayanan S, Mathew J, Paulose CS (2012) Oxidative stress induced NMDA receptor alteration leads to spatial memory deficits in temporal lobe epilepsy: ameliorative effects of Withania somnifera and Withanolide A. Neurochem Res 37:1915–1927
Stan SD, Zeng Y, Singh SV (2008) Ayurvedic medicine constituent withaferin a causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer 60(Suppl 1):51–60
Sukanya DH, Lokesha AN, Datta G, Himabindu K (2010) Phytochemical diversity in ashwagandha (Withania somnifera). J Med Aromat Plants 1(2):TS2-p26
Sultanbawa M, Sotheeswaran S, Balasubramaniam S, Moustafa A-K, Slatkin D, Schiff P Jr (1985) Pachyovatamine, a bisbenzylisoquinoline alkaloid, and other alkaloids from Pachygone ovata. Phytochemistry 24:589–592
Wall ME, Wani M (1977) Antineoplastic agents from plants. Annu Rev Pharmacol Toxicol 17:117–132
Wang HC, Tsai YL, Wu YC, Chang FR, Liu MH, Chen WY, Wu CC (2012) Withanolides-induced breast cancer cell death is correlated with their ability to inhibit heat protein 90. PLoS One 7:e37764
Winters M (2006) Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Altern Med Rev 11:269–277
Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK (2011) Combination of withaferin A and X-ray irradiation enhances apoptosis in U937 cells. Toxicol In Vitro 25:1803–1810
Yu SM, Kim SJ (2013) Production of reactive oxygen species by withaferin A causes loss of type collagen expression and COX-2 expression through the PI3K/Akt, p38, and JNK pathways in rabbit articular chondrocytes. Exp Cell Res 319:2822–2834
Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B (1996) Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 50:69–76
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing AG
About this chapter
Cite this chapter
Rayees, S., Malik, F. (2017). Withania somnifera: From Traditional Use to Evidence Based Medicinal Prominence. In: Kaul, S., Wadhwa, R. (eds) Science of Ashwagandha: Preventive and Therapeutic Potentials. Springer, Cham. https://doi.org/10.1007/978-3-319-59192-6_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-59192-6_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-59191-9
Online ISBN: 978-3-319-59192-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)